Akero Therapeutics
$54.65
31
+$0.1+0.18% Monday 21:00
Statistics
Day High
54.83
Day Low
54.42
52W High
58.4
52W Low
21.34
Volume
14,619,820
Avg. Volume
2,348,865
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
12MarExpected
Expected EPS
-1.001999
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-252.06MNet Income
Analyst Ratings
$54.67Average Price Target
The highest estimate is 56.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 20%
Hold 80%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow AKRO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Madrigal Pharmaceuticals
MDGL
Mkt Cap9.34B
Viking Therapeutics
VKTX
Mkt Cap4.3B
Galmed Pharmaceuticals
GLMD
Mkt Cap7.51M
Gilead Sciences
GILD
Mkt Cap148.78B
Agios Pharmaceuticals
AGIO
Mkt Cap2.52B
Abbvie
ABBV
Mkt Cap385.18B
About
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.
Show more...
CEO
Dr. Andrew Cheng M.D., Ph.D.
Employees
69
Country
US
ISIN
US00973Y1082
Listings
0 Comments
Share your thoughts
FAQ
What is Akero Therapeutics stock price today?▼
The current price of AKRO is $54.65 USD — it has increased by +0.18% in the past 24 hours. Watch Akero Therapeutics stock price performance more closely on the chart.
What is Akero Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Akero Therapeutics stocks are traded under the ticker AKRO.
Is Akero Therapeutics stock price growing?▼
AKRO stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Akero Therapeutics has showed a +30.27% increase.
What is Akero Therapeutics revenue for the last year?▼
Akero Therapeutics revenue for the last year amounts to 0 USD.
What is Akero Therapeutics net income for the last year?▼
AKRO net income for the last year is -252.06M USD.
How many employees does Akero Therapeutics have?▼
As of April 02, 2026, the company has 69 employees.
In which sector is Akero Therapeutics located?▼
Akero Therapeutics operates in the Health Care sector.
When did Akero Therapeutics complete a stock split?▼
Akero Therapeutics has not had any recent stock splits.
Where is Akero Therapeutics headquartered?▼
Akero Therapeutics is headquartered in South San Francisco, US.